ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,308.13
0.09%
US Tech 100
18,182.00
0.62%
다우존스 지수
39,806.77
-0.49%
Bitcoin
70,931.45
-0.72%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. XOMA Corporation (XOMAP)

  7. XOMA Corporation (XOMAP) 뉴스

XOMAP XOMA Corporation

25.02
0.00 (0.00%)
21 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
XOMA Corporation XOMAP 나스닥 우선주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 25.02 09:00:00
개장가 저가 고가 종가 전일 종가
25.25 25.25 25.25 25.02 25.02
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/05/202420:31EDGAR2Form 8-K - Current report
14/05/202420:30GLOBEXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect..
09/05/202420:45EDGAR2Form 8-K - Current report
09/05/202420:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202420:30GLOBEXOMA Reports First Quarter 2024 Financial Results and..
30/04/202420:30GLOBEXOMA Adds Economic Interests in Three First-in-Category..
25/04/202420:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
03/04/202422:00GLOBEXOMA Corporation Announces Closing of Tender Offer
21/03/202420:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
20/03/202405:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
11/03/202419:56EDGAR2Form S-4 - Registration of securities, business combinations
09/03/202406:34EDGAR2Form S-3 - Registration statement under Securities Act of..
08/03/202421:39EDGAR2Form 8-K - Current report
08/03/202421:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
05/03/202407:24EDGAR2Form SC TO-T - Tender offer statement by Third Party
28/02/202421:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
16/02/202423:08EDGAR2Form 8-K - Current report
16/02/202422:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
18/01/202422:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
17/01/202407:22EDGAR2Form SC 13D/A - General statement of acquisition of..
12/01/202406:31EDGAR2Form 8-K - Current report
12/01/202406:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
11/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
02/01/202421:46EDGAR2Form 8-K - Current report
02/01/202421:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
20/12/202321:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
19/12/202321:40EDGAR2Form 8-K - Current report
19/12/202321:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
07/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:40EDGAR2Form 8-K - Current report
07/11/202321:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
31/10/202320:35EDGAR2Form 8-K - Current report
31/10/202320:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
28/10/202306:06EDGAR2Form 8-K - Current report
05/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/09/202320:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
12/09/202305:10EDGAR2Form 8-K - Current report
06/09/202320:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
26/08/202306:09EDGAR2Form 8-K - Current report
08/08/202320:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:35EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
XOMAP
XOMA
BIT
S7SFT1
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유